Non-Small-Cell Lung Cancer Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028

By Type (Squamous Cell Carcinoma, Large Cell Carcinoma, Adenocarcinoma, Others), By Drug Class (Epidermal Growth Factor Receptor (EGFR) Inhibitors, Anaplastic Lymphoma Kinase (ALK) Inhibitors, ROS1 Inhibitors, BRAF Inhibitors, Others), By Treatment (Chemotherapy, Targeted Therapy, Immunotherapy), By End-user (Hospitals & Clinics, Ambulatory Care Centers, Others) By Region and Competition

Published	Pages	Publisher	Report code
Oct 2023	180	TechSci Research	ASDR-638239

Published: Oct 2023 - Pages : 180 - Publisher : TechSci Research - Report code : ASDR-638239

1. Eli Lilly and Company.
2. Sanofi SA
3. Novartis AG
4. F. Hoffmann-La Roche Ltd
5. Merck & Co. Inc.
6. Pfizer Inc.
7. AstraZeneca Plc
8. Boehringer Ingelheim Inc.
9. Bristol-Myers Squibb Company
10. Astellas Pharma

Non-Small Cell Lung Cancer Therapeutics Market - 2025-2033

This report can be of interest as well:

Non-Small Cell Lung Cancer Therapeutics Market - 2025-2033

Published: April, 2025 | Report code: ASDR-675859